SCHEMBL5070137

SCHEMBL5070137

C[N+]1(C)CCC2CCC(C2)C1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.41
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10871049 0.85 CHRNA7 (0.33) CHRNA7
Hydrochloric Acid SCHEMBL5682895 0.82 CHRNA7 (0.32) CHRNA7
SCHEMBL9549405 0.72 CHRNA7 (0.37) CHRNA7
SCHEMBL3226595 0.67 SLC22A2 (0.31)
SCHEMBL1230616 0.67 SLC22A2 (0.31)
SCHEMBL8189 0.67
Methyl Alcohol SCHEMBL949195 0.64
Methyl Alcohol SCHEMBL3184397 0.64 CYP2C9 (0.33)
Methylamine SCHEMBL10602332 0.64 SLC22A2 (0.33)
Iodide SCHEMBL3412585 0.63 CHRNA7 (0.38) CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935103-B1 HYDROCARBON PROCESSES USING UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2024-05-29 EP disclosed
EP-2935103-A1 HYDROCARBON PROCESSES USING UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2015-10-28 EP disclosed
EP-2935104-A1 UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2015-10-28 EP disclosed
US-8993821-B2 Hydrocarbon processes using UZM-43 an EUO-NES-NON zeolite UOP LLC (US) 2015-03-31 US disclosed
US-8916129-B2 UZM-43 an EUO-NES-NON zeolite UOP LLC (US) 2014-12-23 US disclosed
WO-2014099325-A1 HYDROCARBON PROCESSES USING UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2014-06-26 WO disclosed
WO-2014099339-A1 UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2014-06-26 WO disclosed
US-20140171712-A1 HYDROCARBON PROCESSES USING UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2014-06-19 US disclosed
US-20140171291-A1 UZM-43 AN EUO-NES-NON ZEOLITE UOP LLC (US) 2014-06-19 US disclosed
US-7459073-B2 Hydrocarbon conversion using molecular sieve SSZ-47B CHEVRON U.S.A. INC. (US) 2008-12-02 US disclosed
US-20050135998-A1 Method of preventing crystalline intergrowth during the preparation of a crystalline material CHEVRON U.S.A. INC. 2005-06-23 US disclosed
US-20050136000-A1 Molecular sieve SSZ-47B having high micropore volume and synthesis thereof CHEVRON U.S.A. INC. 2005-06-23 US disclosed
US-20050133413-A1 Hydrocarbon conversion using molecular sieve SSZ-47B CHEVRON U.S.A. INC. 2005-06-23 US disclosed
US-6540903-B2 Silicate of given X-ray diffraction pattern; zeolite prepared using a bicyclic quaternary ammonium templating agent; hydrocarbon conversion catalyst; dewaxing; reduction of nitrogen oxides in exhaust gases CHEVRON U.S.A. INC. 2003-04-01 US disclosed
US-6348183-B2 A ZEOLITE HAVING A MOLE RATIO GREATER THAN ABOUT 20 OF AN OXIDE OF A FIRST TETRAVALENT ELEMENT TO AN OXIDE OF A SECOND TETRAVALENT ELEMENT DIFFERENT FROM FIRST TETRAVALENT, TRIVALENT, PENTAVALENT ELEMENTS; USES BICYCLO AMMONIUM CATION CHEVRON U.S.A., INC. 2002-02-19 US disclosed
US-20010027935-A1 Zeolite SSZ-47 LEE GREGORY S (US) 2001-10-11 US disclosed
EP-0952962-B1 ZEOLITE SSZ-47 CHEVRON USA INC (US) 2001-10-10 EP disclosed
US-6290922-B1 REDUCTION OF OXIDES OF NITROGEN CONTAINED IN A GAS STREAM IN THE PRESENCE OF OXYGEN CHEVRON U.S.A. INC. 2001-09-18 US disclosed
US-20010000323-A1 Zeolite SSZ-47 LEE GREGORY S (US) 2001-04-19 US disclosed
US-6156290-A Zeolite SSZ-47 CHEVRON U.S.A. INC. (US) 2000-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050133413-A1 Hydrocarbon conversion using molecular sieve SSZ-47B SF3B5, SPOP, HELZ CHRNA7 3783/4885CYP2C19 1004/4885
US-20010027935-A1 Zeolite SSZ-47 SLC39A14, SFXN3, SFXN1 CHRNA7 3132/4885CYP2C19 2574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.